Eton Pharmaceuticals Inc (ETON) Company Profile & Statistics

Eton Pharmaceuticals Inc
ETON
(Nasdaq - US)
Closed
3.19
+0.13 (+4.25%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
3.09
High
3.19
Low
3.07

About Eton Pharmaceuticals Inc

CEO

Sean E. Brynjelsen

Headquarters

21925 w. field parkway, suite 235

deer park, il 60010, united states

Auditor

KMJ Corbin & Company LLP

Employees

Share Holders

Website

www.etonpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Eton Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	81.95M
Enterprise Value	65.94M
Enterprise Value/EBITDA (ttm)	-378.98
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	5.21
Price to Sales (ttm)	2.55
Price to Cash (ytd)	982.54

Profitability

Gross Margin (ttm)	64.02%
Operating Margin (ttm)	-2.96%
Profit Margin (ttm)	-12.81%
Return on Equity (ttm)	-6.21%
Return on Invested Capital (ttm)	-12.17%
Return on Assets (ttm)	-3.17%

Income Statement

Revenue (ttm)	31.64M
Revenue Per Share (ttm)	1.23
Gross Profit (ttm)	21.06M
EBITDA (ttm)³	-174.00K
Net Income Avi to Common (ttm)	-936.00K
Diluted EPS (ttm)	-0.03

Share Statistics

Beta (5Y Monthly)	1.17
52-Week Change	-12.60%
S&P500 52-Week Change	19.56%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	25.69M
Dividend Yield	0.00%
Float ⁴	22.31M
% Held by Insiders	13.16%
% Held by Institutions	27.86%

Balance Sheet

Total Cash (mrq)	21.39M
Total Cash Per Share (mrq)	0.83
Total Debt (mrq)	5.38M
Total Debt/Equity (mrq)	34.76%
Current Ratio (mrq)	1.65%
Quick Ratio (mrq)	1.60%
Book Value Per Share (mrq)	0.60

Cash Flow

Operating Cash Flow Per Share (ytd)	0.27
Free Cash Flow (ytd)	6.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Eton Pharmaceuticals Inc

Trade With A Regulated Broker